Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence

Mayo Clinic
31 Jan, 2020 ,

Study to prospectively collect blood and tumor tissue from esophageal cancer patients to identify specific esophageal cancer mutations that can be measured in the blood (cell-free DNA) during the course of treatment as a marker of response and recurrence.